Abstract

The effect of botulinum neurotoxin A (BoNT-A) in stroke patients' upper limbs has been attributed to its peripheral action only. However, BoNT-A depressed recurrent inhibition of lumbar motoneurons, likely due to its retrograde transportation along motor axons affecting synapses to Renshaw cells. Because Renshaw cells control group Ia interneurons mediating reciprocal inhibition between antagonists, we tested whether this inhibition, particularly affected after stroke, could recover after BoNT-A. The effect of posterior tibial nerve (PTN) stimulation on tibialis anterior (TA) electromyogram (EMG) was investigated in 13 stroke patients during treadmill walking before and 1 month after BoNT-A injection in ankle plantar flexors. Before BoNT-A, PTN stimuli enhanced TA EMG all during the swing phase. After BoNT-A, the PTN-induced reciprocal facilitation in TA motoneurons was depressed at the beginning of swing and reversed into inhibition in midswing, but at the end of swing, the reciprocal facilitation was enhanced. This suggests that BoNT-A induced spinal plasticity leading to the recovery of reciprocal inhibition likely due to the withdrawal of inhibitory control from Renshaw cells directly blocked by the toxin. At the end of swing, the enhanced reciprocal facilitation might be due to BoNT-induced modification of peripheral afferent inputs. Therefore, both central and peripheral actions of BoNT-A can modify muscle synergies during walking: (1) limiting ankle muscle co-contraction in the transition phase from stance to swing, to assist dorsiflexion, and (2) favoring it from swing to stance, which blocks the ankle joint and thus assists the balance during the single support phase on the paretic limb.

Highlights

  • Post-stroke walking is characterized by coactivation of ankle flexors and extensors

  • Because their spinal excitability did not change after muscular injection in forearm muscles, it has been claimed that Botulinum neurotoxin A (BoNT-A) clinical effect is only limited to its peripheral action in stroke patients (Girlanda et al 1997)

  • BoNT-A, it started ~300 msec before the foot contact in the patient illustrated in Figure 2A and B

Read more

Summary

Introduction

Post-stroke walking is characterized by coactivation of ankle flexors and extensors. Botulinum neurotoxin A (BoNT-A), indicated to paralyze overactive ankle plantar flexors, improves the temporal pattern of electromyographic (EMG) activity and the patients recover better alternated ankle muscle activities (Hesse et al 1996). Besides its well-known action at peripheral level, BoNT-A can affect central activity by influencing afferent inputs through its action on gamma motor endings (Filippi et al 1993; Rosales et al 1996), by inducing plastic changes following the blockade of the neuromuscular transmission (Abbruzzese and Berardelli 2006; Caleo et al 2009), and through its retrograde transport along the motor axons (Antonucci et al 2008; Torii et al 2011) Because their spinal excitability did not change after muscular injection in forearm muscles, it has been claimed that BoNT-A clinical effect is only limited to its peripheral action in stroke patients (Girlanda et al 1997).

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call